{"id": "article-151527_0", "title": "Orbital Solitary Fibrous Tumor -- Introduction", "content": "Solitary fibrous tumors (SFTs) encompass the histological spectrum of rare, slow-growing\u00a0fibroblastic tumors considered mesenchymal in origin and arising from mesenchymal fibroblast-like cells. This class of neoplasms includes tumors previously classified as hemangiopericytomas. [1] [2] Originally described in the pleura, SFTs have subsequently been described in several extrapleural sites, including the peritoneum, liver, mediastinum, upper respiratory tract, kidney, adrenal gland, bladder, prostate, orbit, nose, paranasal structures, and other sites in the head and neck. [3] The largest published series of patients with extra-meningeal SFTs found these neoplasms widely distributed in the following sites: 31% of SFTs originated within the abdominal cavity, 29% within the extremities, 22% from the pleurae, 11% from the trunk, and 7% from other sites, including the head and neck but excluding the meninges. [4]", "contents": "Orbital Solitary Fibrous Tumor -- Introduction. Solitary fibrous tumors (SFTs) encompass the histological spectrum of rare, slow-growing\u00a0fibroblastic tumors considered mesenchymal in origin and arising from mesenchymal fibroblast-like cells. This class of neoplasms includes tumors previously classified as hemangiopericytomas. [1] [2] Originally described in the pleura, SFTs have subsequently been described in several extrapleural sites, including the peritoneum, liver, mediastinum, upper respiratory tract, kidney, adrenal gland, bladder, prostate, orbit, nose, paranasal structures, and other sites in the head and neck. [3] The largest published series of patients with extra-meningeal SFTs found these neoplasms widely distributed in the following sites: 31% of SFTs originated within the abdominal cavity, 29% within the extremities, 22% from the pleurae, 11% from the trunk, and 7% from other sites, including the head and neck but excluding the meninges. [4]"}
{"id": "article-151527_1", "title": "Orbital Solitary Fibrous Tumor -- Introduction", "content": "The orbital SFT was first described in 1994 in separate reports by Dorfman and Westra. [5] Orbital SFTs pose a diagnostic challenge; they are rare neoplasms that present similarly to other orbital lesions. Orbital SFTs rarely metastasize and are treated with complete surgical excision. [6] Patients with an orbital SFT typically present with nonspecific symptoms characterized by slowly progressive, unilateral eyelid, eye, or periorbital swelling, proptosis,\u00a0edema, or a palpable mass.", "contents": "Orbital Solitary Fibrous Tumor -- Introduction. The orbital SFT was first described in 1994 in separate reports by Dorfman and Westra. [5] Orbital SFTs pose a diagnostic challenge; they are rare neoplasms that present similarly to other orbital lesions. Orbital SFTs rarely metastasize and are treated with complete surgical excision. [6] Patients with an orbital SFT typically present with nonspecific symptoms characterized by slowly progressive, unilateral eyelid, eye, or periorbital swelling, proptosis,\u00a0edema, or a palpable mass."}
{"id": "article-151527_2", "title": "Orbital Solitary Fibrous Tumor -- Etiology", "content": "SFTs were initially thought to be mesothelial tumors as they tend to arise from the pleurae and mediastinum. Klemperer and Robin initially described an SFT in 1931 as a \u201clocalized mesothelioma.\u201d [7] Since then,\u00a0SFTs have been described in several extra-serosal tissues, including the lung, liver, thyroid, sinuses, and orbit. These extra-serosal\u00a0tumors likely originate from non-mesothelial tissues, possibly fibroblast-like differentiated cells within the mesenchyme.\u00a0Endoneural dendritic cells, cutaneous dendrocytes, and pericytes are all possible sources of origin.", "contents": "Orbital Solitary Fibrous Tumor -- Etiology. SFTs were initially thought to be mesothelial tumors as they tend to arise from the pleurae and mediastinum. Klemperer and Robin initially described an SFT in 1931 as a \u201clocalized mesothelioma.\u201d [7] Since then,\u00a0SFTs have been described in several extra-serosal tissues, including the lung, liver, thyroid, sinuses, and orbit. These extra-serosal\u00a0tumors likely originate from non-mesothelial tissues, possibly fibroblast-like differentiated cells within the mesenchyme.\u00a0Endoneural dendritic cells, cutaneous dendrocytes, and pericytes are all possible sources of origin."}
{"id": "article-151527_3", "title": "Orbital Solitary Fibrous Tumor -- Etiology", "content": "While the exact etiology of orbital SFTs remains unclear, their electron microscopic morphology and intense staining with CD34 and vimentin are compatible with a fibroblastic differentiated cell line. [5] [8] [9] Current research suggests abnormal cellular differentiation and genetic mutations may contribute to developing orbital SFTs.", "contents": "Orbital Solitary Fibrous Tumor -- Etiology. While the exact etiology of orbital SFTs remains unclear, their electron microscopic morphology and intense staining with CD34 and vimentin are compatible with a fibroblastic differentiated cell line. [5] [8] [9] Current research suggests abnormal cellular differentiation and genetic mutations may contribute to developing orbital SFTs."}
{"id": "article-151527_4", "title": "Orbital Solitary Fibrous Tumor -- Epidemiology", "content": "Approximately 20% of all SFTs occur in the head and neck. [10] Orbital\u00a0SFTs are rare\u00a0and account for less than 1% of all orbital tumors. Orbital\u00a0SFTs and SFTs of the extremities are among the most commonly\u00a0reported extrapleural SFTs. [11] Orbital SFTs occur equally in males and females. While there are reports of orbital SFTs in children as young as 5 years, most cases occur in adults between the ages of 20 and 70; the median age at diagnosis is 40. [12] [13] [14]", "contents": "Orbital Solitary Fibrous Tumor -- Epidemiology. Approximately 20% of all SFTs occur in the head and neck. [10] Orbital\u00a0SFTs are rare\u00a0and account for less than 1% of all orbital tumors. Orbital\u00a0SFTs and SFTs of the extremities are among the most commonly\u00a0reported extrapleural SFTs. [11] Orbital SFTs occur equally in males and females. While there are reports of orbital SFTs in children as young as 5 years, most cases occur in adults between the ages of 20 and 70; the median age at diagnosis is 40. [12] [13] [14]"}
{"id": "article-151527_5", "title": "Orbital Solitary Fibrous Tumor -- Epidemiology", "content": "Fewer than 10% of patients with pleural SFTs develop paraneoplastic disorders such as hypertrophic osteoarthropathy (HOA). HOA syndrome is more common than paraneoplastic hypoglycemia, and HOA may be underdiagnosed in SFT. Other findings associated with SFTs include low blood glucose, growth hormone, and insulin-like growth factor I or III levels. [15] However, paraneoplastic features related to orbital SFTs have not been reported in the literature.", "contents": "Orbital Solitary Fibrous Tumor -- Epidemiology. Fewer than 10% of patients with pleural SFTs develop paraneoplastic disorders such as hypertrophic osteoarthropathy (HOA). HOA syndrome is more common than paraneoplastic hypoglycemia, and HOA may be underdiagnosed in SFT. Other findings associated with SFTs include low blood glucose, growth hormone, and insulin-like growth factor I or III levels. [15] However, paraneoplastic features related to orbital SFTs have not been reported in the literature."}
{"id": "article-151527_6", "title": "Orbital Solitary Fibrous Tumor -- Pathophysiology", "content": "SFTs are classified as low-aggressive, high-aggressive, or dedifferentiated. [15] [16] Ultrastructural, immunohistochemical, and microscopic investigations of SFTs\u00a0have revealed that neoplastic cells have mesenchymal, submesothelial, and fibroblastic origin. [7] Staining for markers CD34, bcl-2, and CD99 is helpful but nondiagnostic; morphological correlation is often required. [2] [8] CD34\u00a0is expressed in most\u00a0SFTs but is also common in dermatofibrosarcomas, neural tumors, epithelioid sarcomas, and Kaposi sarcomas. [2] [8] CD99 and bcl-2 are also expressed by mesenchymal tumors such as rhabdomyosarcoma, Ewing sarcoma, and osteosarcoma. [17] [18]", "contents": "Orbital Solitary Fibrous Tumor -- Pathophysiology. SFTs are classified as low-aggressive, high-aggressive, or dedifferentiated. [15] [16] Ultrastructural, immunohistochemical, and microscopic investigations of SFTs\u00a0have revealed that neoplastic cells have mesenchymal, submesothelial, and fibroblastic origin. [7] Staining for markers CD34, bcl-2, and CD99 is helpful but nondiagnostic; morphological correlation is often required. [2] [8] CD34\u00a0is expressed in most\u00a0SFTs but is also common in dermatofibrosarcomas, neural tumors, epithelioid sarcomas, and Kaposi sarcomas. [2] [8] CD99 and bcl-2 are also expressed by mesenchymal tumors such as rhabdomyosarcoma, Ewing sarcoma, and osteosarcoma. [17] [18]"}
{"id": "article-151527_7", "title": "Orbital Solitary Fibrous Tumor -- Pathophysiology", "content": "The intense expression of CD34 helps differentiate SFTs from hemangiopericytomas and fibrous histiocytomas.\u00a0CD34 is fairly sensitive for SFT\u00a0but\u00a0relatively nonspecific. [8] [17] [18] Neural schwannomas exhibit CD34\u00a0expression. [19] Orbital SFTs are usually negative for biomarkers desmin, CD31, EMA, s-100 protein, and smooth muscle actin. Hence,\u00a0positivity to mesenchymal markers and negativity to epithelial and muscular biomarkers justify the suggested mesenchymal origin of SFTs. [17]", "contents": "Orbital Solitary Fibrous Tumor -- Pathophysiology. The intense expression of CD34 helps differentiate SFTs from hemangiopericytomas and fibrous histiocytomas.\u00a0CD34 is fairly sensitive for SFT\u00a0but\u00a0relatively nonspecific. [8] [17] [18] Neural schwannomas exhibit CD34\u00a0expression. [19] Orbital SFTs are usually negative for biomarkers desmin, CD31, EMA, s-100 protein, and smooth muscle actin. Hence,\u00a0positivity to mesenchymal markers and negativity to epithelial and muscular biomarkers justify the suggested mesenchymal origin of SFTs. [17]"}
{"id": "article-151527_8", "title": "Orbital Solitary Fibrous Tumor -- Pathophysiology", "content": "STAT6 is a signal transducer and transcription activator, and strong nuclear staining of STAT6 has been identified as a hallmark of SFT by immunohistochemistry. In contrast to the protein product of NAB2 , which typically operates within the nucleus as a transcriptional repressor through its interaction with EGR1 , STAT6 encodes for a cytoplasmic proteinaceous transcription factor continually shuttled to the nucleus. The transcriptional activator NAB2-STAT6 promotes the expression of EGR1 target genes. STAT6 may\u00a0induce fibrosis in the setting of wound healing involving macrophages, CD4 T H 2 cells, and fibroblasts via IL-13 signaling. [4] [20]", "contents": "Orbital Solitary Fibrous Tumor -- Pathophysiology. STAT6 is a signal transducer and transcription activator, and strong nuclear staining of STAT6 has been identified as a hallmark of SFT by immunohistochemistry. In contrast to the protein product of NAB2 , which typically operates within the nucleus as a transcriptional repressor through its interaction with EGR1 , STAT6 encodes for a cytoplasmic proteinaceous transcription factor continually shuttled to the nucleus. The transcriptional activator NAB2-STAT6 promotes the expression of EGR1 target genes. STAT6 may\u00a0induce fibrosis in the setting of wound healing involving macrophages, CD4 T H 2 cells, and fibroblasts via IL-13 signaling. [4] [20]"}
{"id": "article-151527_9", "title": "Orbital Solitary Fibrous Tumor -- Histopathology", "content": "In general, SFTs\u00a0vary significantly in size, with most reported lesions being less than 10 cm. While a giant orbital\u00a0SFT measuring 15 cm in the greatest dimension has been reported in the literature, most orbital SFTS measure from 1 to 3 cm. [21] SFTs are usually well-circumscribed, lobulated, yellow, and solitary. True capsules and pseudo capsules are infrequently\u00a0reported in the\u00a0literature. [11]", "contents": "Orbital Solitary Fibrous Tumor -- Histopathology. In general, SFTs\u00a0vary significantly in size, with most reported lesions being less than 10 cm. While a giant orbital\u00a0SFT measuring 15 cm in the greatest dimension has been reported in the literature, most orbital SFTS measure from 1 to 3 cm. [21] SFTs are usually well-circumscribed, lobulated, yellow, and solitary. True capsules and pseudo capsules are infrequently\u00a0reported in the\u00a0literature. [11]"}
{"id": "article-151527_10", "title": "Orbital Solitary Fibrous Tumor -- Histopathology", "content": "Orbital\u00a0SFTs demonstrate\u00a0haphazardly arranged sheets of spindle cells with dull nuclei and nonapparent nucleoli. [8] [22] Microscopically, patternless fibroblastic cells alternating with bundles of collagen and embedded vascular channels are surrounded by pericytes. [23] [24] The arrangement of cellular and stromal components in SFT is referred to as a patternless pattern. [15] (see Image. Host-Pathological Examination, Orbital Solitary Fibrous Tumors)", "contents": "Orbital Solitary Fibrous Tumor -- Histopathology. Orbital\u00a0SFTs demonstrate\u00a0haphazardly arranged sheets of spindle cells with dull nuclei and nonapparent nucleoli. [8] [22] Microscopically, patternless fibroblastic cells alternating with bundles of collagen and embedded vascular channels are surrounded by pericytes. [23] [24] The arrangement of cellular and stromal components in SFT is referred to as a patternless pattern. [15] (see Image. Host-Pathological Examination, Orbital Solitary Fibrous Tumors)"}
{"id": "article-151527_11", "title": "Orbital Solitary Fibrous Tumor -- Histopathology", "content": "Several risk categorization models for localized resected extra-meningeal SFT have been published, 2 of which have been externally verified. These verified models provide a more accurate prediction of metastatic risk, dividing patients into\u00a03 risk categories based on patient age, mitotic count, and tumor size and necrosis. [15] [4] Mitosis and necrosis are rarely reported as typical features of orbital SFTs. However, nuclear atypia, increased cellularity, necrosis, and greater than 4 mitotic figures per hpf\u00a0suggest malignancy and aggressive infiltration, necessitating en bloc removal and long-term follow-up. [24]", "contents": "Orbital Solitary Fibrous Tumor -- Histopathology. Several risk categorization models for localized resected extra-meningeal SFT have been published, 2 of which have been externally verified. These verified models provide a more accurate prediction of metastatic risk, dividing patients into\u00a03 risk categories based on patient age, mitotic count, and tumor size and necrosis. [15] [4] Mitosis and necrosis are rarely reported as typical features of orbital SFTs. However, nuclear atypia, increased cellularity, necrosis, and greater than 4 mitotic figures per hpf\u00a0suggest malignancy and aggressive infiltration, necessitating en bloc removal and long-term follow-up. [24]"}
{"id": "article-151527_12", "title": "Orbital Solitary Fibrous Tumor -- Histopathology", "content": "Chung et al reported that 50% of orbital SFTs patients had positive STAT6 expression. [9] STAT6 nuclear staining, in combination with CD34 positivity, is a valuable diagnostic adjunct in distinguishing SFT from histologic imitators. [25]", "contents": "Orbital Solitary Fibrous Tumor -- Histopathology. Chung et al reported that 50% of orbital SFTs patients had positive STAT6 expression. [9] STAT6 nuclear staining, in combination with CD34 positivity, is a valuable diagnostic adjunct in distinguishing SFT from histologic imitators. [25]"}
{"id": "article-151527_13", "title": "Orbital Solitary Fibrous Tumor -- History and Physical", "content": "Orbital\u00a0SFTs usually present with painless and slowly progressive eye swelling over months to years. Proptosis is the most common finding in patients with an orbital SFT (see Image. Clinical Photograph of Proptosis). The optic nerve is rarely compressed or infiltrated, although vision, pupillary reaction, and visual fields may be affected. [24] Patients may report diplopia, tearing, and eyelid swelling. [9] [26] The extraocular muscles may be restricted due to tumor encroachment; this is the proposed mechanism behind diplopia and is particularly common in anterior tumors. [24] Measuring proptosis with an exophthalmometer is important in identifying and diagnosing orbital SFTs.", "contents": "Orbital Solitary Fibrous Tumor -- History and Physical. Orbital\u00a0SFTs usually present with painless and slowly progressive eye swelling over months to years. Proptosis is the most common finding in patients with an orbital SFT (see Image. Clinical Photograph of Proptosis). The optic nerve is rarely compressed or infiltrated, although vision, pupillary reaction, and visual fields may be affected. [24] Patients may report diplopia, tearing, and eyelid swelling. [9] [26] The extraocular muscles may be restricted due to tumor encroachment; this is the proposed mechanism behind diplopia and is particularly common in anterior tumors. [24] Measuring proptosis with an exophthalmometer is important in identifying and diagnosing orbital SFTs."}
{"id": "article-151527_14", "title": "Orbital Solitary Fibrous Tumor -- Evaluation", "content": "Imaging plays an important role in the diagnosis of orbital SFTs.\u00a0Orbital SFTs may be intraconal, extraconal, or intraconal and extraconal; extraconal tumors appear to be most common. [27] SFTs of the ocular adnexa are\u00a0uncommon, typically manifest as persistent orbital masses with proptosis, and usually originate within the lacrimal gland, lacrimal sac, or eyelid. [26] [27] As observed in other locations, SFTs of the ocular adnexa exhibit STAT6 expression. [28]", "contents": "Orbital Solitary Fibrous Tumor -- Evaluation. Imaging plays an important role in the diagnosis of orbital SFTs.\u00a0Orbital SFTs may be intraconal, extraconal, or intraconal and extraconal; extraconal tumors appear to be most common. [27] SFTs of the ocular adnexa are\u00a0uncommon, typically manifest as persistent orbital masses with proptosis, and usually originate within the lacrimal gland, lacrimal sac, or eyelid. [26] [27] As observed in other locations, SFTs of the ocular adnexa exhibit STAT6 expression. [28]"}
{"id": "article-151527_15", "title": "Orbital Solitary Fibrous Tumor -- Evaluation", "content": "When imaged with computed tomography (CT) or magnetic resonance imaging (MRI), orbital SFTs usually appear as well-defined soft tissue masses with occasional calcifications (see Image. Computed Tomography Image of Orbital Solitary Fibrous Tumor). [29] Bony remodeling can be observed in long-standing tumors; the bony destruction characteristic of malignant neoplasms has not been reported. [30] [31] Orbital SFTs enhance with contrast in both imaging modalities. [32] [26] Heterogeneity following contrast injection was more common in aggressive SFTs than indolent SFTs, at 76.5% and 40.0%, respectively. [33]", "contents": "Orbital Solitary Fibrous Tumor -- Evaluation. When imaged with computed tomography (CT) or magnetic resonance imaging (MRI), orbital SFTs usually appear as well-defined soft tissue masses with occasional calcifications (see Image. Computed Tomography Image of Orbital Solitary Fibrous Tumor). [29] Bony remodeling can be observed in long-standing tumors; the bony destruction characteristic of malignant neoplasms has not been reported. [30] [31] Orbital SFTs enhance with contrast in both imaging modalities. [32] [26] Heterogeneity following contrast injection was more common in aggressive SFTs than indolent SFTs, at 76.5% and 40.0%, respectively. [33]"}
{"id": "article-151527_16", "title": "Orbital Solitary Fibrous Tumor -- Evaluation", "content": "Tumor enhancement on CT and MRI is affected by the vascularity of the tumor, capillary permeability, and renal clearance. [34] Orbital SFTs are isointense on T1-weighted MRI\u00a0and isointense to hypointense on T2-weighted\u00a0scans, reflecting\u00a0fibrous tissue with high collagen content. [27] [26] [30] [31] [35] [36] [37] [38] However, T2-weighted images\u00a0may reveal patchy hyperintense signaling consistent with internal bleeding, cystic degeneration, or very recent fibrosis. [31] [38] [39] [34] Strong enhancement with gadolinium is typically observed with vascular tumors. [15] [40]", "contents": "Orbital Solitary Fibrous Tumor -- Evaluation. Tumor enhancement on CT and MRI is affected by the vascularity of the tumor, capillary permeability, and renal clearance. [34] Orbital SFTs are isointense on T1-weighted MRI\u00a0and isointense to hypointense on T2-weighted\u00a0scans, reflecting\u00a0fibrous tissue with high collagen content. [27] [26] [30] [31] [35] [36] [37] [38] However, T2-weighted images\u00a0may reveal patchy hyperintense signaling consistent with internal bleeding, cystic degeneration, or very recent fibrosis. [31] [38] [39] [34] Strong enhancement with gadolinium is typically observed with vascular tumors. [15] [40]"}
{"id": "article-151527_17", "title": "Orbital Solitary Fibrous Tumor -- Treatment / Management", "content": "Orbital SFTs are generally treated\u00a0with\u00a0en bloc, total surgical excision, given the penchant for recurrence and possible malignant degeneration in incompletely resected tumors. Exenteration may be required for infiltrating malignant tumors, as radiotherapy and chemotherapy have demonstrated limited benefit. [26] [41] [42] [43] Recurrence is uncommon but usually occurs after an incomplete primary excision. [44] [45]", "contents": "Orbital Solitary Fibrous Tumor -- Treatment / Management. Orbital SFTs are generally treated\u00a0with\u00a0en bloc, total surgical excision, given the penchant for recurrence and possible malignant degeneration in incompletely resected tumors. Exenteration may be required for infiltrating malignant tumors, as radiotherapy and chemotherapy have demonstrated limited benefit. [26] [41] [42] [43] Recurrence is uncommon but usually occurs after an incomplete primary excision. [44] [45]"}
{"id": "article-151527_18", "title": "Orbital Solitary Fibrous Tumor -- Treatment / Management", "content": "Preoperative embolization can shrink tumor size, reducing intraoperative bleeding and surgical time. Liquid, particles, or coils can be used for embolization. Liquid embolic agents are commonly used for aneurysms, arteriovenous malformations, and fistulas, while coils are preferred for occluding large vessels. There has been a case report of a large orbital SFT preoperatively embolized with 500- to 700-\u00b5m tris-acryl gelatin microspheres. [46] [47]", "contents": "Orbital Solitary Fibrous Tumor -- Treatment / Management. Preoperative embolization can shrink tumor size, reducing intraoperative bleeding and surgical time. Liquid, particles, or coils can be used for embolization. Liquid embolic agents are commonly used for aneurysms, arteriovenous malformations, and fistulas, while coils are preferred for occluding large vessels. There has been a case report of a large orbital SFT preoperatively embolized with 500- to 700-\u00b5m tris-acryl gelatin microspheres. [46] [47]"}
{"id": "article-151527_19", "title": "Orbital Solitary Fibrous Tumor -- Treatment / Management", "content": "Surgical techniques for resecting orbital tumors include the fronto-orbital\u00a0or pteronial approaches and lateral or medial orbitotomy. The size and location of the neoplasm dictate the method employed.\u00a0The transcranial fronto-orbital\u00a0approach is employed to treat intracranial lesions involving the optic canal or occurring medial to the optic nerve at the apex. [13] Intraoperative use of the ultrasonic aspirator system SONO-PET to fragment neoplastic tissue for removal while simultaneously irrigating and aspirating the operative field may be beneficial. [48]", "contents": "Orbital Solitary Fibrous Tumor -- Treatment / Management. Surgical techniques for resecting orbital tumors include the fronto-orbital\u00a0or pteronial approaches and lateral or medial orbitotomy. The size and location of the neoplasm dictate the method employed.\u00a0The transcranial fronto-orbital\u00a0approach is employed to treat intracranial lesions involving the optic canal or occurring medial to the optic nerve at the apex. [13] Intraoperative use of the ultrasonic aspirator system SONO-PET to fragment neoplastic tissue for removal while simultaneously irrigating and aspirating the operative field may be beneficial. [48]"}
{"id": "article-151527_20", "title": "Orbital Solitary Fibrous Tumor -- Treatment / Management", "content": "Additionally, stereotactic radiosurgery may be performed to treat benign and malignant tumors or vascular abnormalities. Although data is lacking, stereotactic radiosurgery may be a suitable alternative for adjuvant treatment following partial resection of orbital SFTs or to treat recurrence. [49] [50] Tata et al reported a case of a recurrent orbital SFT treated with gamma knife radiosurgery, resulting in effective tumor control and regression. [50] Clinical monitoring with serial examinations and imaging can be cautiously performed in individuals who have undergone previous tumor resection. [9]", "contents": "Orbital Solitary Fibrous Tumor -- Treatment / Management. Additionally, stereotactic radiosurgery may be performed to treat benign and malignant tumors or vascular abnormalities. Although data is lacking, stereotactic radiosurgery may be a suitable alternative for adjuvant treatment following partial resection of orbital SFTs or to treat recurrence. [49] [50] Tata et al reported a case of a recurrent orbital SFT treated with gamma knife radiosurgery, resulting in effective tumor control and regression. [50] Clinical monitoring with serial examinations and imaging can be cautiously performed in individuals who have undergone previous tumor resection. [9]"}
{"id": "article-151527_21", "title": "Orbital Solitary Fibrous Tumor -- Differential Diagnosis", "content": "The differential diagnosis of orbital SFTs includes other tumors that can cause proptosis, such as schwannomas, hemangiomas, fibrous histiocytomas, meningiomas, and hemangiopericytomas. [51] Capillary hemangiomas are the most prevalent orbital vascular tumors in infants and children, and cavernous hemangiomas are the most prevalent vascular orbital tumors in adults.", "contents": "Orbital Solitary Fibrous Tumor -- Differential Diagnosis. The differential diagnosis of orbital SFTs includes other tumors that can cause proptosis, such as schwannomas, hemangiomas, fibrous histiocytomas, meningiomas, and hemangiopericytomas. [51] Capillary hemangiomas are the most prevalent orbital vascular tumors in infants and children, and cavernous hemangiomas are the most prevalent vascular orbital tumors in adults."}
{"id": "article-151527_22", "title": "Orbital Solitary Fibrous Tumor -- Differential Diagnosis", "content": "Capillary hemangiomas typically grow fastest in the first 6 months of life and then begin to involute. [52] Although enhancing characteristics demonstrated on CT and MR imaging may be similar to those of orbital SFTs, an orbital capillary hemangioma can be distinguished by its infiltrative nature, nodular and irregular margin, and hyperintensity on T2-weighted MR images. [52] Cavernous hemangiomas appear as well-defined oval masses when imaged with CT and MRI\u00a0and most commonly occur within the intrazonal area of the orbit. Cavernous hemangiomas are distinguished from orbital SFTs by hyperintensity with fibrous septa on T2-weighted MR images and different enhancing properties, demonstrating delayed pooling of contrast material on dynamic investigations. [52]", "contents": "Orbital Solitary Fibrous Tumor -- Differential Diagnosis. Capillary hemangiomas typically grow fastest in the first 6 months of life and then begin to involute. [52] Although enhancing characteristics demonstrated on CT and MR imaging may be similar to those of orbital SFTs, an orbital capillary hemangioma can be distinguished by its infiltrative nature, nodular and irregular margin, and hyperintensity on T2-weighted MR images. [52] Cavernous hemangiomas appear as well-defined oval masses when imaged with CT and MRI\u00a0and most commonly occur within the intrazonal area of the orbit. Cavernous hemangiomas are distinguished from orbital SFTs by hyperintensity with fibrous septa on T2-weighted MR images and different enhancing properties, demonstrating delayed pooling of contrast material on dynamic investigations. [52]"}
{"id": "article-151527_23", "title": "Orbital Solitary Fibrous Tumor -- Differential Diagnosis", "content": "It is imperative to differentiate hemangiopericytomas and orbital SFTs; the treatments differ, and hemangiopericytomas have a\u00a0propensity for recurrence and metastasis.\u00a0Hemangiopericytomas are somatic soft tissue neoplasms that are well-encapsulated, highly vascular, and commonly found in the extra-orbital region near the paranasal sinuses. [52] [53] In imaging studies, orbital\u00a0hemangiopericytomas may be the most difficult tumors to distinguish from\u00a0orbital SFTs. Hemangiopericytomas may be associated with bone erosion or infiltration into neighboring tissues.\u00a0On both T1 and T2-weighted MR images, hemangiopericytomas\u00a0are isointense to the gray matter. [52] Inconspicuous contrast enhancement can also be seen in orbital schwannoma, neurofibroma, fibrous histiocytoma, lymphoma, pseudotumor, and metastatic disease. [54]", "contents": "Orbital Solitary Fibrous Tumor -- Differential Diagnosis. It is imperative to differentiate hemangiopericytomas and orbital SFTs; the treatments differ, and hemangiopericytomas have a\u00a0propensity for recurrence and metastasis.\u00a0Hemangiopericytomas are somatic soft tissue neoplasms that are well-encapsulated, highly vascular, and commonly found in the extra-orbital region near the paranasal sinuses. [52] [53] In imaging studies, orbital\u00a0hemangiopericytomas may be the most difficult tumors to distinguish from\u00a0orbital SFTs. Hemangiopericytomas may be associated with bone erosion or infiltration into neighboring tissues.\u00a0On both T1 and T2-weighted MR images, hemangiopericytomas\u00a0are isointense to the gray matter. [52] Inconspicuous contrast enhancement can also be seen in orbital schwannoma, neurofibroma, fibrous histiocytoma, lymphoma, pseudotumor, and metastatic disease. [54]"}
{"id": "article-151527_24", "title": "Orbital Solitary Fibrous Tumor -- Prognosis", "content": "The prognosis of orbital SFTs will vary with several factors, including the size, location, extent of invasion, and histological characteristics\u00a0of the neoplasm. For wholly resected\u00a0tumors, the prognosis is generally excellent. Approximately 75% of SFTs have a benign course, with the remaining 25% exhibiting invasion to surrounding tissues, recurrence, or distant metastasis. Moreover, 95% of recurrent orbital SFTs have benign histology, while up to 75% of histopathologically verified malignant tumors have nonaggressive clinical behavior.", "contents": "Orbital Solitary Fibrous Tumor -- Prognosis. The prognosis of orbital SFTs will vary with several factors, including the size, location, extent of invasion, and histological characteristics\u00a0of the neoplasm. For wholly resected\u00a0tumors, the prognosis is generally excellent. Approximately 75% of SFTs have a benign course, with the remaining 25% exhibiting invasion to surrounding tissues, recurrence, or distant metastasis. Moreover, 95% of recurrent orbital SFTs have benign histology, while up to 75% of histopathologically verified malignant tumors have nonaggressive clinical behavior."}
{"id": "article-151527_25", "title": "Orbital Solitary Fibrous Tumor -- Prognosis", "content": "Tumor recurrence can occur as soon as 3 months or as long as 40 years after primary excision. [12] Furthermore, the involvement of certain critical structures within the orbit, such as the optic nerve or major blood vessels, can significantly impact the prognosis\u00a0of orbital SFTs. Tumors located near vital structures may be more challenging to excise completely, leading to an increased risk of complications, potential functional impairment, and recurrence.", "contents": "Orbital Solitary Fibrous Tumor -- Prognosis. Tumor recurrence can occur as soon as 3 months or as long as 40 years after primary excision. [12] Furthermore, the involvement of certain critical structures within the orbit, such as the optic nerve or major blood vessels, can significantly impact the prognosis\u00a0of orbital SFTs. Tumors located near vital structures may be more challenging to excise completely, leading to an increased risk of complications, potential functional impairment, and recurrence."}
{"id": "article-151527_26", "title": "Orbital Solitary Fibrous Tumor -- Complications", "content": "Space-occupying lesions can cause complications due to direct mass effects.\u00a0Compressive optic neuropathy is the most common complication of large intraconal orbital SFTs. Chronic pain, paresthesia, and glaucoma are possible complications of infiltrating malignant orbital SFTs. [55]", "contents": "Orbital Solitary Fibrous Tumor -- Complications. Space-occupying lesions can cause complications due to direct mass effects.\u00a0Compressive optic neuropathy is the most common complication of large intraconal orbital SFTs. Chronic pain, paresthesia, and glaucoma are possible complications of infiltrating malignant orbital SFTs. [55]"}
{"id": "article-151527_27", "title": "Orbital Solitary Fibrous Tumor -- Complications", "content": "Any surgical resection of an orbital mass carries the risks\u00a0of retrobulbar hemorrhage, diplopia, ptosis, strabismus, reduced vision, blindness, postoperative inflammation, cellulitis, or inadequate tumor excision. [56] Recurrence or malignant transformation\u00a0may result from incomplete tumor removal. Close monitoring following orbital surgery is critical. [57]", "contents": "Orbital Solitary Fibrous Tumor -- Complications. Any surgical resection of an orbital mass carries the risks\u00a0of retrobulbar hemorrhage, diplopia, ptosis, strabismus, reduced vision, blindness, postoperative inflammation, cellulitis, or inadequate tumor excision. [56] Recurrence or malignant transformation\u00a0may result from incomplete tumor removal. Close monitoring following orbital surgery is critical. [57]"}
{"id": "article-151527_28", "title": "Orbital Solitary Fibrous Tumor -- Postoperative and Rehabilitation Care", "content": "Patients whose tumors have been completely excised may benefit from routine follow-up. In contrast, those\u00a0with incomplete tumor removal should be monitored more frequently, undergoing serial imaging to monitor for tumor recurrence. Long-term surveillance can aid in detecting potential tumor regrowth or metastasis and ensure timely intervention if required. [58]", "contents": "Orbital Solitary Fibrous Tumor -- Postoperative and Rehabilitation Care. Patients whose tumors have been completely excised may benefit from routine follow-up. In contrast, those\u00a0with incomplete tumor removal should be monitored more frequently, undergoing serial imaging to monitor for tumor recurrence. Long-term surveillance can aid in detecting potential tumor regrowth or metastasis and ensure timely intervention if required. [58]"}
{"id": "article-151527_29", "title": "Orbital Solitary Fibrous Tumor -- Consultations", "content": "An ophthalmologist should thoroughly evaluate any patient presenting with an orbital mass, restriction of extraocular movements, diplopia, proptosis, ptosis, or the sudden onset of periorbital swelling. Referral to an ocular oncologist or oculoplastic surgeon may be required. Further consultations with a retina or glaucoma specialist may be required if the patient develops intraocular complications. [58]", "contents": "Orbital Solitary Fibrous Tumor -- Consultations. An ophthalmologist should thoroughly evaluate any patient presenting with an orbital mass, restriction of extraocular movements, diplopia, proptosis, ptosis, or the sudden onset of periorbital swelling. Referral to an ocular oncologist or oculoplastic surgeon may be required. Further consultations with a retina or glaucoma specialist may be required if the patient develops intraocular complications. [58]"}
{"id": "article-151527_30", "title": "Orbital Solitary Fibrous Tumor -- Deterrence and Patient Education", "content": "Patients with orbital SFTs must be counseled regarding the significance and importance of postoperative follow-up to monitor for disease reoccurrence. Patients with small, asymptomatic tumors may elect to be observed with serial examination and imaging studies.", "contents": "Orbital Solitary Fibrous Tumor -- Deterrence and Patient Education. Patients with orbital SFTs must be counseled regarding the significance and importance of postoperative follow-up to monitor for disease reoccurrence. Patients with small, asymptomatic tumors may elect to be observed with serial examination and imaging studies."}
{"id": "article-151527_31", "title": "Orbital Solitary Fibrous Tumor -- Enhancing Healthcare Team Outcomes", "content": "Orbital\u00a0SFTs are very rare neoplasms. Healthcare\u00a0practitioners\u00a0should know the nonspecific early indicators of an orbital mass,\u00a0 including proptosis, vision loss, limited extraocular muscle movements, ptosis, and eyelid swelling. Although the primary management of orbital\u00a0SFTs is surgical excision, some patients with small tumors may elect to be observed with serial examinations and imaging studies. [59]", "contents": "Orbital Solitary Fibrous Tumor -- Enhancing Healthcare Team Outcomes. Orbital\u00a0SFTs are very rare neoplasms. Healthcare\u00a0practitioners\u00a0should know the nonspecific early indicators of an orbital mass,\u00a0 including proptosis, vision loss, limited extraocular muscle movements, ptosis, and eyelid swelling. Although the primary management of orbital\u00a0SFTs is surgical excision, some patients with small tumors may elect to be observed with serial examinations and imaging studies. [59]"}
{"id": "article-151527_32", "title": "Orbital Solitary Fibrous Tumor -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Orbital Solitary Fibrous Tumor -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}